findings at 72 months indicate that antiestrogen therapy ( tamoxifen , nolvadex ) added to chemotherapy with cyclophosphamide ( cytoxan ) , methotrexate , and fluorouracil ( 5-fluorouracil ) ( cmf ) resulted in significant delayed recurrence in er-positive postmenopausal patients , er-positive patients with four or more positive nodes , and er-positive patients with tumors greater than 3 cm in diameter .
C0016360
5-fluorouracil
C0950521
cmf